Unmet Needs in hATTR Amyloidosis

Due to the complex and varied symptoms related to hATTR amyloidosis, early diagnosis is rare. And misdiagnosis is common. There is an unjustifiable lack of equity to treatment for hATTR amyloidosis across Europe. Although therapies are approved at a European level, access across individual countries varies.